| Application no. and date | 10766694.3 (espacenet) (Federated) (European Patent Register), 20100406 | | Patent/reg. no. and date | DK/EP 2421888, 20180221 | | Publication date | 20120229 | | Priority no. and date | FI 20090161, 20090422 | | EP pub. no. and date |
EP 2421888 20120229 | | Effective date | | | Applicant/owner | Faron Pharmaceuticals OY, Joukahaisenkatu 6
20520 Turku, FI | | Applicant ref. no. | P64440DK01 | | Inventor | JALKANEN, Sirpa, Rauvolantie 79
FI-20760 Piispanristi, FI,
SALMI, Marko, Anniitunkatu 22
FI-20900 Turku, FI,
JALKANEN, Markku, Rauvolantie 79
FI-20760 Piispanristi, FI | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 31/58 (2006.01) , A61K 35/15 (2015.01) , A61K 38/17 (2006.01) , A61K 38/20 (2006.01) , A61K 39/00 (2006.01) , C07K 16/28 (2006.01) , C12N 15/113 (2010.01) , C12N 15/115 (2010.01) , C12Q 1/68 (2018.01) | | Title | CLEVER-1-receptor-antagonister til blokering af immun-inhibitorisk type 2 makrofager | | Int. application no. | FI2010050266 | | Int. publication no. | WO2010122217 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
